Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.
作者信息
Shi Zhongxun, Li Bing, Huang Huijun, Qin Tiejun, Xu Zefeng, Zhang Hongli, Fang Liwei, Pan Lijuan, Hu Naibo, Qu Shiqiang, Huang Gang, Gale Robert P, Xiao Zhijian
机构信息
MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
State Key Laboratory of Experimental Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
出版信息
Br J Haematol. 2019 Jul;186(2):352-355. doi: 10.1111/bjh.15830. Epub 2019 Mar 5.
Abstract
摘要
相似文献
1
Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.
Br J Haematol. 2019 Jul;186(2):352-355. doi: 10.1111/bjh.15830. Epub 2019 Mar 5.
2
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes.
Ann Hematol. 2020 Jan;99(1):189-191. doi: 10.1007/s00277-019-03863-z. Epub 2019 Nov 26.
3
Calculator-free point-of-care prognostication in myelodysplastic syndromes.
Am J Hematol. 2019 Apr;94(4):E99-E101. doi: 10.1002/ajh.25400. Epub 2019 Jan 24.
4
[Prognostic significance red blood cell distribution width in myelodysplastic syndromes].
Zhonghua Xue Ye Xue Za Zhi. 2022 Aug 14;43(8):686-690. doi: 10.3760/cma.j.issn.0253-2727.2022.08.013.
5
Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome.
Leuk Res. 2018 Apr;67:56-59. doi: 10.1016/j.leukres.2018.02.004. Epub 2018 Feb 7.
6
Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes.
Ann Hematol. 2010 Jul;89(7):671-9. doi: 10.1007/s00277-010-0912-6. Epub 2010 Feb 24.
7
Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Leuk Res. 2006 Mar;30(3):247-53. doi: 10.1016/j.leukres.2005.07.003. Epub 2005 Aug 15.
8
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3.
9
De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes.
Br J Haematol. 2020 Jun;189(6):e237-e240. doi: 10.1111/bjh.16669. Epub 2020 Apr 27.
10
Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases.
Leukemia. 2010 Mar;24(3):640-2. doi: 10.1038/leu.2009.229. Epub 2009 Nov 5.
引用本文的文献
1
Diagnosis of myelodysplastic syndromes: the classic and the novel.
Haematologica. 2025 Feb 1;110(2):300-311. doi: 10.3324/haematol.2023.284937.
2
How we diagnose Myelodysplastic syndromes.
Front Oncol. 2024 Sep 13;14:1415101. doi: 10.3389/fonc.2024.1415101. eCollection 2024.
3
The elevation of red blood cell distribution width is an independent prognostic factor for juvenile myelomonocytic leukemia.
Blood Sci. 2024 Apr 25;6(2):e00186. doi: 10.1097/BS9.0000000000000186. eCollection 2024 Apr.
4
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma.
Sci Rep. 2024 Feb 3;14(1):2832. doi: 10.1038/s41598-024-53385-6.
5
[Prognostic significance red blood cell distribution width in myelodysplastic syndromes].
Zhonghua Xue Ye Xue Za Zhi. 2022 Aug 14;43(8):686-690. doi: 10.3760/cma.j.issn.0253-2727.2022.08.013.
6
Evaluation and validation of the prognostic value of platelet indices in patients with leukemia.
Clin Exp Med. 2023 Oct;23(6):1835-1844. doi: 10.1007/s10238-022-00985-z. Epub 2023 Jan 9.
7
Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes.
Front Oncol. 2022 Apr 1;12:846044. doi: 10.3389/fonc.2022.846044. eCollection 2022.
8
The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
Blood Adv. 2021 Dec 28;5(24):5584-5587. doi: 10.1182/bloodadvances.2021005974.
9
The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome.
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):332-335. doi: 10.1016/j.htct.2020.11.007. Epub 2021 Jan 29.
10
Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma.
Cancers (Basel). 2020 Nov 4;12(11):3262. doi: 10.3390/cancers12113262.
本文引用的文献
1
Prediction of acute myeloid leukaemia risk in healthy individuals.
Nature. 2018 Jul;559(7714):400-404. doi: 10.1038/s41586-018-0317-6. Epub 2018 Jul 9.
2
The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?
Br J Haematol. 2018 Dec;183(5):815-819. doi: 10.1111/bjh.15036. Epub 2017 Nov 28.
3
New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes.
Am Soc Clin Oncol Educ Book. 2017;37:480-494. doi: 10.1200/EDBK_175397.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Revised international prognostic scoring system for myelodysplastic syndromes.
Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27.
6
Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach.
Cytokine. 2012 May;58(2):193-8. doi: 10.1016/j.cyto.2012.01.005. Epub 2012 Feb 5.
7
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Clin Cancer Res. 2004 Nov 1;10(21):7252-9. doi: 10.1158/1078-0432.CCR-04-0713.
Zotero 插件